The Global Biopharmaceuticals Market Growth Accelerated By Innovation In Product Development
![]() |
Biopharmaceuticals Market |
Biopharmaceuticals including monoclonal antibodies,
vaccines, stem cell and gene therapy have significantly improved the treatment
of various life-threatening diseases like cancer, infectious diseases and rare
genetic disorders. These biologics are developed in living systems and are
highly complex entities.
The global Biopharmaceuticals Market is estimated to be
valued at US$ 397.24 Bn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
One of the key trends driving the growth of the biopharmaceuticals market is
the continuous innovation in the development of novel products.
Biopharmaceutical companies are extensively investing in research and
development to come up with more effective and targeted treatment solutions.
They are leveraging advanced technologies like gene therapy and cellular
therapies to develop next-generation biologics. For instance, chimeric antigen
receptor (CAR) T-cell therapy is a breakthrough in cancer treatment that
harnesses the body's immune system to target cancer cells. Several biopharma
players are conducting clinical trials for CAR T-cell therapies for different
cancer types. Moreover, companies are exploring opportunities in areas like
regenerative medicines to develop therapies for chronic diseases like heart
disease and Parkinson's disease through stem cell and tissue engineering
approaches. Such innovative product pipelines focusing on unmet medical needs
are expected to boost the demand for biopharmaceuticals during the forecast
period.
Segment Analysis
The global biopharmaceuticals market is dominated by monoclonal antibodies
subsegment. Monoclonal antibodies drugs segment is dominating the market
because of increasing demand for targeted therapies for cancer and autoimmune
diseases. Monoclonal antibodies are highly specific, act on specific targets
and offer less side effects as compared to conventional drugs, thus driving
their demand.
Key Takeaways
The global
Biopharmaceuticals market analysis is expected to witness high growth.
The market is estimated to grow at a CAGR of 9.4% during the forecast period of
2023-2030. The market size is projected to reach US$ 397.24 Bn by 2024.
Regional analysis
North America region currently dominates the biopharmaceuticals market and
is expected to continue its dominance during the forecast period. High adoption
of biopharmaceutical drugs for treating chronic diseases along with presence of
major biopharmaceutical companies in the US and Canada are major factors
contributing to North America's large market share. Asia Pacific region is
expected to showcase fastest growth rate owing to increasing penetration of
biologics in emerging Asian countries such as China and India supported by
improving healthcare infrastructure and rising spending on healthcare.
Key players
Key players operating in the biopharmaceuticals market are Accenture,
Teleperformance SE, Infosys Limited (Infosys BPM), WNS (Holdings) Ltd., HCL
Technologies Limited, AMDOCS, CBRE Group Inc., Sodexo, NCR Corporation, TTEC
Holdings, Inc., Wipro Limited, and Capgemini. Accenture is a global leader in
biopharmaceutical consulting services. Teleperformance SE is a global leader in
outsourcing customer services. Infosys BPM is a leader in providing transformed
BPM services to global biopharmaceutical companies.
Get
more insights on this topic: https://www.newswirestats.com/biopharmaceuticals-market-industry-insights-trends-biopharmaceuticals-market/
Explore
more information on this topic, Please visit: https://filmik.in/molecular-cytogenetics-the-future-of-genomic-research/
Comments
Post a Comment